IR Medtek
IR Medtek is a medical device company founded in 2019 that exclusively licensed technology from The Ohio State University and the James Cancer Hospital for the early, non-invasive detection of skin and other cancers. The technology utilizes light detection, machine learning, and advanced algorithms. IR Medtek aims to improve healthcare outcomes by providing medical professionals with enhanced information for better and more timely care. The company has completed two clinical studies and is conducting two more to further advance the technology, with the initial goal of commercializing it into various medical devices.
IR Medtek
IR Medtek is a medical device company founded in 2019 that exclusively licensed technology from The Ohio State University and the James Cancer Hospital for the early, non-invasive detection of skin and other cancers. The technology utilizes light detection, machine learning, and advanced algorithms. IR Medtek aims to improve healthcare outcomes by providing medical professionals with enhanced information for better and more timely care. The company has completed two clinical studies and is conducting two more to further advance the technology, with the initial goal of commercializing it into various medical devices.